史赛克Stryker Corporation（SYK）2025年第一季度业绩报告「NYSE」（英文版）（8页）.pdf

1、 1 1941 Stryker Way Portage,MI 49002 Press release Number:25-16 Date:May 1,2025 Stryker reports first quarter 2025 operating results Portage,Michigan May 1,2025 Stryker(NYSE:SYK)reported operating results for the first quarter of 2025:First Quarter Results Reported net sales increased 11.9%to$5.9 bi

2、llion Organic net sales increased 10.1%Reported operating income margin of 14.3%Adjusted operating income margin(1)increased 100 bps to 22.9%Reported EPS decreased 17.6%to$1.69 Adjusted EPS(1)increased 13.6%to$2.84 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant C

3、urrency Acquisitions/Divestitures Organic MedSurg and Neurotechnology 13.4%(0.8)%14.2%3.5%10.7%Orthopaedics 9.7 (1.0)10.7 1.4 9.3 Total 11.9%(0.9)%12.8%2.7%10.1%“Our 2024 momentum continued into the first quarter as we delivered double-digit organic sales growth and continued to expand adjusted oper

4、ating margins,”said Kevin A.Lobo,Chair and CEO.“We remain confident in our sales and earnings power for 2025,fueled by the strength of procedural volumes,demand for our capital products and our commercial execution.”Sales Analysis Consolidated net sales of$5.9 billion increased 11.9%in the quarter a

5、nd 12.8%in constant currency.Organic net sales increased 10.1%in the quarter including 9.4%from increased unit volume and 0.7%from higher prices.MedSurg and Neurotechnology net sales of$3.5 billion increased 13.4%in the quarter and 14.2%in constant currency.Organic net sales increased 10.7%in the qu

6、arter including 9.5%from increased unit volume and 1.2%from higher prices.Orthopaedics net sales of$2.4 billion increased 9.7%in the quarter and 10.7%in constant currency.Organic net sales increased 9.3%in the quarter including 9.3%from increased unit volume.Earnings Analysis Reported net earnings o